Merck to Lower Prices on Some Drugs, but Not its Blockbusters
The drugs singled out for discounts include the flagging hepatitis C treatment Zepatier and six drugs that have lost their patent protection.
from NYT > Politics https://ift.tt/2LqiJo6
from NYT > Politics https://ift.tt/2LqiJo6
Comments
Post a Comment